Mary Harney joined the CTxONE Board of Directors in June 2020. She is a cross sectoral specialist with two decades of board and C-suite Executive experience and a breadth of expertise across all aspects of Business Management in the agricultural, health, pharmaceutical and biotechnology spheres. As CEO of Royal Australasian College of Surgeons, and Gardiner Dairy Research Foundation, the Director of the Office of Clinical Research/COO Research at Peter MacCallum Cancer Centre and Director of Corporate Development at Bioproperties Pty Ltd, she has had carriage of strategy development, risk management and the development of best practice corporate, research and clinical governance.
Mary has held the Company Secretary role on three occasions since 2000 at Cerylid Biosciences Ltd, the Gardiner Dairy Research Foundation and the Royal Australasian College of Surgeons. She was on the board of the RACS Foundation for Surgery and board committees (Audit and Risk Committees, Governance and People Development) for RACS and Gardiner Foundation.
Mary has undergraduate degrees in science and art history from Monash University and University of Melbourne respectively and international postgraduate qualifications in diagnostic Cytopathology. In 2015, she was the collaborative winner, with Monash of the AFR and B-HERT for excellence in collaboration between industry and academia for the dairy industry. In 2016, she was awarded the Science Alumni of the Year award from Monash University.
Mary is a Fellow of the Institute of Managers, Member of the Australian Institute of Company Directors (AICD) and completed the AICD course in 2000. In 2017, she completed ‘Strategy in the Age of Digital Disruption’ at INSEAD Business School (Global #1 Business School).
Mr Tim Murphy
Tim Murphy has held a number of non-executive director positions including Chair, Deputy Chair and numerous subcommittee role in sectors from youth support to indigenous affairs, insurance, clinical trial management, medical research and healthcare delivery.
He is a politically astute executive with extensive experience working with the C-suite and the Boardroom to manage corporate issues in regulated environments. He uses his experiences in high-growth, merger, consolidation, and downsizing global and national business environments to ensure the long-term viability of the organisations he supports.
Tim is a Fellow of the Australian Institute of Company Directors and in 2011 was awarded Lifetime membership of BioMelbourne Network for his contribution to its inception and development.
Michael Vovos has been working in Intellectual Property management and Commercialisation for over 23 years with a career that included working with Universities, Institutes, Joint Ventures and Biotech companies. During this time, Michael has been involved with the creation of technology spin-out companies, numerous licensing opportunities and technology transfer transactions.
Notable career achievements include involvement in several R&D Syndicates that bought in millions of dollars of research funding, the creation of a start-up company that manufactured bio-degradable plastics, numerous license transactions – one that brought in $20 million dollar up-front payments. In addition Michael has worked with the Food and Packaging CRC, worked to establish the Innovative Dairy Products CRC and was involved in the establishment of the CRC for Mental Health. Michael’s expertise was recognized when he was approached to be part of the team that was charged with the rescue and stabilization of the Australian Stem Cell Centre and this activity also lead him to assist with the creation of the legacy vehicle – The National Stem Cell foundation of Australia